Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Moinfar, F; Azodi, M; Tavassoli, FA.
Uterine sarcomas.
PATHOLOGY. 2007; 39(1): 55-71.
Doi: 10.1080/00313020601136146
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Moinfar Farid
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- A wide variety of sarcomas occur in the uterus but two subtypes - leiomyosarcoma and endometrial stromal sarcoma - account for a majority of those more routinely encountered. Using the 2003 World Health Organization classification, this review focuses on six uterine sarcomas: endometrial stromal sarcoma, undifferentiated endometrial sarcoma, leiomyosarcoma, rhabomyosarcoma, angiosarcoma and liposarcoma. The epidemiological, clinical, pathological and molecular features are presented along with therapeutic approaches. Familiarity with molecular aspects of these tumors and application of novel technologies in their assessment should be encouraged as they may provide alternate therapies resulting in improved survival for the patient. Clinical information necessary for accurate diagnosis of these lesions is emphasised. A multidisciplinary approach to management of patients with uterine sarcomas is essential for optimal management.
- Find related publications in this database (using NLM MeSH Indexing)
-
Antineoplastic Agents - therapeutic use
-
Female - therapeutic use
-
Humans - therapeutic use
-
Sarcoma - diagnosis
-
Selective Estrogen Receptor Modulators - adverse effects
-
Tamoxifen - adverse effects
-
Uterine Neoplasms - diagnosis
- Find related publications in this database (Keywords)
-
endometrial stromal sarcoma
-
ESS
-
leiomyosarcoma
-
LMS
-
undifferentiated endometrial sarcoma
-
UES
-
rhabdomyosarcoma
-
angiosarcoma
-
liposarcoma
-
tamoxifen
-
JAZF1/ JJAZ1 fusion
-
CD44 V3
-
frequency of allelic loss
-
FAL